title: [The therapeutic benefits of systemic treatment of psoriatic arthritis? The example of golimumab in psoriatic arthritis].
authors.affiliation: Service de rhumatologie, hôpital de Hautepierre, avenue Molière, 67098 Strasbourg cedex, France. boulinguez.s@chu-toulouse.fr
authors.forename: Serge
authors.initials: S
authors.lastname: Boulinguez
authors.forename: Jean
authors.initials: J
authors.lastname: Sibilia
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000473:pathology; D019317:Evidence-Based Medicine; D006801:Humans; D011788:Quality of Life; D011859:Radiography; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; C529000:golimumab